Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-19 @ 3:42 AM
Study NCT ID:
NCT04501666
Status:
COMPLETED
Last Update Posted:
2024-07-10
First Post:
2020-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-30
First Submit QC Date:
None
Study First Post Date:
2020-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-16
Results First Submit QC Date:
None
Results First Post Date:
2024-07-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-07-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-07-04
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL